PressSeptember 24, 2022 Irwin Naturals Inc Announces Normal Course Issuer Bid for Subordinate Voting Shares of the Corporation
PressSeptember 24, 2022 Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada
PressSeptember 24, 2022 Core One Labs Signs Letter of Intent with GMP Manufacturing Partner for Production of Proprietary Psychedelic Compounds
PressSeptember 24, 2022 Mydecine Innovations Group Announces Closing Under Share Subscription Agreement and Welcomes New CFO
PressSeptember 22, 2022 Origin Therapeutics’ Portfolio Company, Xpira Pharmaceuticals, Receives FDA Approval For Psilocybin Trial IND Application
PressSeptember 22, 2022 Nirvana Life Sciences Inc. Deuterates 7-Hydroxymitragynine to Create D7-h, an Analogue that May Improve Research and Formulations using Kratom Derivatives
PressSeptember 22, 2022 Ketamine Wellness Centers (KWC) Partners with Veterans Administration Community Care Network (VA-CCN) To Expand SPRAVATO® Coverage
PressSeptember 22, 2022 Numinus Expands Ketamine Therapy for Mental Health in Montreal and announces new brand awareness initiatives
BlogSeptember 21, 2022 Algernon Pharmaceuticals Announces Receipt of CDN $450K Cash Refund from Australian Research Program
PressSeptember 21, 2022 Biomind Labs Announces Completion of Dosing in Phase II Trial of Its DMT-Based Inhaled Formulation BMND01 for Treatment-Resistant Depression
PressSeptember 21, 2022 Cybin Achieves Research and Development Milestones Ahead of Projected Timelines
PressSeptember 21, 2022 COMPASS Pathways to participate in upcoming Jefferies Innovation in Mental Health Summit
PressSeptember 20, 2022 Bexson Biomedical Announces Renowned Scientist, Engineer and Inventor, Robert S. Langer ScD, Joins Its Scientific Advisory Board
PressSeptember 20, 2022 MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances
PressSeptember 20, 2022 Optimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to its Business and Become Industry Leader in Psychedelic Enhanced Psychotherapy
